212 related articles for article (PubMed ID: 18768535)
1. Median parameters for Down's syndrome screening should be calculated using a moving time-window method.
Reynolds TM; Aldis J
Ann Clin Biochem; 2008 Nov; 45(Pt 6):567-70. PubMed ID: 18768535
[TBL] [Abstract][Full Text] [Related]
2. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
3. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
Reynolds T; Ellis A; Jones R
Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
Reynolds TM; Vranken G; Van Nueten J; Aldis J
Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
[TBL] [Abstract][Full Text] [Related]
5. [Maternal serum screening for Down's syndrome: a user's club experience].
Bernard M; Brochet C; Kerguelen S; Bréchard MP; Dudragne D; Luthier B; Régnier-Vigouroux G; Yerokine P
Ann Biol Clin (Paris); 2002; 60(4):476-80. PubMed ID: 12147454
[TBL] [Abstract][Full Text] [Related]
6. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
7. [Evaluating the applicability of MoM in second trimester maternal serum to screening for Down's syndrome in Jiangsu province].
Xu BY; Hu Y; Zhang CY; Zhang JW; Liu QL; Yue H; Ru T; Xu ZF; Zhu RF; Zhang Y; Zhong X; Wu QM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):32-5. PubMed ID: 18247300
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
Spencer K
Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
[No Abstract] [Full Text] [Related]
9. Down's syndrome screening marker levels following assisted reproduction.
Barkai G; Goldman B; Ries L; Chaki R; Dor J; Cuckle H
Prenat Diagn; 1996 Dec; 16(12):1111-4. PubMed ID: 8994246
[TBL] [Abstract][Full Text] [Related]
10. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
11. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
Christiansen M; Høgdall EV; Larsen SO; Høgdall C
Prenat Diagn; 2002 May; 22(5):385-7. PubMed ID: 12001192
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Watt HC; George L
Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
14. Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
Seifer DB; MacLaughlin DT; Cuckle HS
Hum Reprod; 2007 Apr; 22(4):1017-20. PubMed ID: 17218369
[TBL] [Abstract][Full Text] [Related]
15. Optimization of regional median equations of prenatal screening markers for trisomy 21 in a Chinese population.
Xu L; Huang H; Zheng L; He D; Lin N; Wang L; Lin Y
Medicine (Baltimore); 2018 Aug; 97(35):e12045. PubMed ID: 30170416
[TBL] [Abstract][Full Text] [Related]
16. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
Morris JK; Bestwick J; Wald NJ
J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
[TBL] [Abstract][Full Text] [Related]
17. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.
Borrell A; Borobio V; Bestwick JP; Wald NJ
J Med Screen; 2009; 16(3):112-8. PubMed ID: 19805751
[TBL] [Abstract][Full Text] [Related]
18. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum screening for Down syndrome in Mainland China.
Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
[No Abstract] [Full Text] [Related]
20. Placental synthesis of oestriol in Down's syndrome pregnancies.
Newby D; Aitken DA; Howatson AG; Connor JM
Placenta; 2000; 21(2-3):263-7. PubMed ID: 10736251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
